Systemic administration of morphine induced a hyperalgesic response in the hot plate test, at an extremely low dose (1-10 lg/kg). We have examined in vivo whether morphine, at an extremely low dose, induces acute central hypernociception following activation of the opioid receptor-mediated PLC/PKC inositol-lipid signaling pathway. The PLC inhibitor U73122 and the PKC blocker, calphostin C, dose dependently prevented the thermal hypernociception induced by morphine. This effect was also prevented by pretreatment with aODN against PLCb 3 at 2 nmol/mouse and PKCc at 2-3 nmol/mouse. Low dose morphine hyperalgesia was dose dependently reversed by selective NMDA antagonist MK801 and ketamine. This study demonstrates the presence of a nociceptive PLCb 3 /PKCc/NMDA pathway stimulated by low concentrations of morphine, through lOR 1 receptor, in mouse brain. This signaling pathway appears to play an opposing role in morphine analgesia. When mice were treated with a morphine analgesic dose (7 mg/kg), the downregulation of PLCb 3 or PKCc at the same aODN doses used for the prevention of the hyperalgesic effect induced, respectively, a 46% and 67% potentiation in analgesic response. Experimental and clinical studies suggest that opioid may activate pronociceptive systems, leading to pain hypersensitivity and short-term tolerance, a phenomenon encountered in postoperative pain management by acute opioid administration. The clinical management of pain by morphine may be revisited in light of the identification of the signaling molecules of the hyperalgesic pathway. Ó
Introduction
A growing body of evidence suggests that lOR opioid agonists induce not only analgesia, but may also enhance sensitivity to pain. This paradoxical effect has been demonstrated both in clinical (Guignard et al., 2000; Angst et al., 2003; Compton et al., 2003) and laboratory studies (Laulin et al., 1998; Celerier et al., 1999 Celerier et al., , 2000 Celerier et al., , 2001 Laulin et al., 2002; Van Elstraete et al., 2005) . Morphine, at higher doses, induces analgesia. The alkaloid, via opioid receptors and PTX sensitive inhibitory G protein (G i ), inhibits cyclic AMP (cAMP) formation, Ca 2+ conductance and activates K + conductance leading to hyperpolarization of a cell and exerting an inhibitory effect (Nestler, 1992) . Otherwise, extremely low doses of morphine (1-10 lg/kg) can elicit acute hyperalgesia in animal models of pain, i.e., tail flick, Freund's adjuvant-induced arthritic rats (Kayan et al., 
